| Group | Study initiation(months) | Between-Subjects Effects | |||
---|---|---|---|---|---|---|
0 | 3 | 6 | F | P | ||
CD4% | Control (n = 4) | 33.94 ± 8.49 | 34.16 ± 1.99 | 25.02 ± 7.28 | 12.252 | 0.004** |
LTNP (n = 4) | 27.17 ± 5.79 | 23.77 ± 6.20 | 20.09 ± 4.78 | |||
Progressors (n = 4) | 17.12 ± 5.09 | 15.52 ± 5.46 | 13.41 ± 4.55 | |||
CD8% | Control (n = 4) | 21.37 ± 5.60 | 22.61 ± 3.01 | 17.25±2.47 | 3.453 | 0.083 |
LTNP (n = 4) | 41.62 ± 16.47 | 33.24 ± 8.03 | 31.35 ± 8.20 | |||
Progressors (n = 4) | 35.54 ± 11.45 | 26.10 ± 5.05 | 31.26 ± 10.91 | |||
CD4/CD8 | Control (n = 4) | 1.6 ± 0.22 | 1.52 ± 0.14 | 1. 43±0.25 | 40.946 | 0.000** |
LTNP (n = 4) | 0.75 ± 0.32 | 0.76 ± 0.31 | 0.66 ± 0.11 | |||
Progressors (n = 4) | 0.49 ± 0.11 | 0.59 ± 0.20 | 0. 48 ± 0.29 |